| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/15/2001 | CA2383782A1 Compounds for the treatment of viral infections |
| 03/15/2001 | CA2383776A1 Method for generating immune-compatible cells and tissues using nuclear transfer techniques |
| 03/15/2001 | CA2383731A1 Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-ones and their use as lipase inhibitors |
| 03/15/2001 | CA2383729A1 Bile acid-substituted phenyl-alkenoylguanidines, method for producing said phenyl-alkenoylguanidines, use thereof as medicaments or diagnostic reagents and medicaments containing the same |
| 03/15/2001 | CA2383721A1 Use of 2-pyridylcarboxaldehyde isonicotinoyl hydrazone analogues as iron chelators |
| 03/15/2001 | CA2383578A1 Food product and process for manufacturing same |
| 03/15/2001 | CA2383523A1 Cross-linked agent for generation of a long-lasting satiety effect and method for the production of the said |
| 03/15/2001 | CA2383186A1 Method to identify gene function using small molecule probes |
| 03/15/2001 | CA2383148A1 Natural physiologically active substances efficacious against fish parasites and fish feeds containing the substances |
| 03/15/2001 | CA2383086A1 Non-peptidic cyclophilin binding compounds and their use |
| 03/15/2001 | CA2382161A1 Immunoglobulin superfamily polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2382130A1 Novel chalcones |
| 03/15/2001 | CA2382112A1 Chalcone coumarins |
| 03/15/2001 | CA2381581A1 Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity |
| 03/15/2001 | CA2380763A1 Aminoalkoxy carbazoles for the treatment of cns diseases |
| 03/15/2001 | CA2348067A1 Composition for extending post meal satiety |
| 03/15/2001 | CA2318004A1 Novel polyamine analogues as therapeutic and diagnostic agents |
| 03/15/2001 | CA2286408A1 The use of msm |
| 03/14/2001 | EP1083178A1 Tetrahydroquinazoline-2,4-diones and therapeutic uses thereof |
| 03/14/2001 | EP1083177A1 Compounds capable of cleaving double-stranded dna and method of utilization of the same |
| 03/14/2001 | EP1083175A2 Triazole derivatives having antifungal activity |
| 03/14/2001 | EP1083172A1 N-substituted derivatives of 5-oxyiminobarbituric acid |
| 03/14/2001 | EP1083171A1 Pyrazoline derivatives, their preparation and application as medicaments |
| 03/14/2001 | EP1083170A1 Method for producing D-(3'-Pyridyl)-alanine |
| 03/14/2001 | EP1083168A1 Prostaglandin derivative |
| 03/14/2001 | EP1082966A1 Anti-inflammatory eye drops |
| 03/14/2001 | EP1082963A1 Remedies for joint diseases bound to hyaluronic acid |
| 03/14/2001 | EP1082962A1 UTILIZATION OF 2-HYDROXY-4-TRIFLUOROMETHYLBENZO C ACID DERIVATIVES AS INHIBITORS OF THE ACTIVATION OF THE NUCLEAR TRANSCRIPTION FACTORS NF-$g(k)B |
| 03/14/2001 | EP1082961A1 Sleep inducing agent |
| 03/14/2001 | EP1082960A2 Use of CRF antagonists and related compositions for treating depression and modifying the circadian rhytm |
| 03/14/2001 | EP1082959A1 NK1 Antagonists for the treatment of depression |
| 03/14/2001 | EP1082958A2 5-HT1F agonists in chronic pain |
| 03/14/2001 | EP1082956A1 Organogel comprising a hydrophilic oxidation-sensitive compound and its use, particularly in cosmetics |
| 03/14/2001 | EP1082909A1 Steroidal sapogenins for the control of coccidiosis in animals |
| 03/14/2001 | EP1082908A1 Additives for crustacean or fish feeds and feeds |
| 03/14/2001 | EP1082809A1 Methods of suppressing reference oscillator harmonic interference and related receivers |
| 03/14/2001 | EP1082462A1 Identification of molecular interaction sites in rna for novel drug discovery |
| 03/14/2001 | EP1082444A1 Adeno-associated virus vectors and uses thereof |
| 03/14/2001 | EP1082432A2 Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof |
| 03/14/2001 | EP1082338A1 17 beta-nitro-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 03/14/2001 | EP1082337A1 17 beta-amino and hydroxylamino-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 03/14/2001 | EP1082336A2 Apoptosis modulators that interact with the huntington's disease gene |
| 03/14/2001 | EP1082335A1 Novel secreted and membrane-associated proteins and uses therefor |
| 03/14/2001 | EP1082331A1 Platinum complex conjugated to cyclotriphosphazene, its preparation, and anticancer agent comprising the same |
| 03/14/2001 | EP1082330A1 Platinum complex, its preparation and therapeutic application |
| 03/14/2001 | EP1082329A1 Platinum complex, its preparation and therapeutic application |
| 03/14/2001 | EP1082326A1 Cephalosporines having cyclic aminoguanidine substituents as antibiotics |
| 03/14/2001 | EP1082325A1 Naphthosulfamylmethyl penem antibacterials |
| 03/14/2001 | EP1082324A1 Imidazopyridine thrombin inhibitors |
| 03/14/2001 | EP1082323A2 Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them |
| 03/14/2001 | EP1082322A2 Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them |
| 03/14/2001 | EP1082321A1 Heterocyclic derivatives which inhibit factor xa |
| 03/14/2001 | EP1082320A1 Novel substituted imidazole compounds |
| 03/14/2001 | EP1082319A1 Benzocarbazol and indenoinole derived estrogenic agents |
| 03/14/2001 | EP1082315A1 Potassium channel inhibitors |
| 03/14/2001 | EP1082314A1 New dipeptidyl peptidase iv effectors |
| 03/14/2001 | EP1082313A1 Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 03/14/2001 | EP1082311A1 Quinazolines for treating brain tumor |
| 03/14/2001 | EP1082310A1 Methods of identifying and using hla binding compounds as hla-agonists and antagonists |
| 03/14/2001 | EP1082308A1 Heterocyclically substituted amides used as calpain inhibitors |
| 03/14/2001 | EP1082306A1 Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel |
| 03/14/2001 | EP1082305A1 Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 03/14/2001 | EP1082304A1 NEW CRYSTALLINE POLYMORPHIC FORM OF 1-METHYL-5-p-TOLUOYLPYRROLE-2-ACETAMIDOACETIC ACID GUAIACYL ESTER (MED 15) |
| 03/14/2001 | EP1082303A1 Heterocyclic derivatives which inhibit factor xa |
| 03/14/2001 | EP1082302A1 A vla-4 inhibitor: omepupa-v |
| 03/14/2001 | EP1082301A1 Ureas and carbamates of n-heterocyclic carboxylic acids and carboxylic acid isosteres |
| 03/14/2001 | EP1082300A1 3-[(1'-n-methylamino)ethyl-n-benzyl]pyrrolidine monomethanesulfonate |
| 03/14/2001 | EP1082299A1 C11 oxymyl and hydroxylamino prostaglandins useful as medicaments |
| 03/14/2001 | EP1082298A2 1$g(a)-HYDROXY-25-ENE-VITAMIN D, ANALOGS AND USES THEREOF |
| 03/14/2001 | EP1082294A1 Phenylalanine derivatives as integrin inhibitors |
| 03/14/2001 | EP1082293A2 Formoterol polymorphs |
| 03/14/2001 | EP1082292A2 Control of pain with endogenous cannabinoids |
| 03/14/2001 | EP1082289A1 Methods for identifying novel multimeric agents that modulate receptors |
| 03/14/2001 | EP1082155A2 Dry powder dispersing apparatus and methods for their use |
| 03/14/2001 | EP1082138A1 Texaphyrin conjugates and uses thereof |
| 03/14/2001 | EP1082134A2 Composition comprising tumor cells and extracts and method of using thereof |
| 03/14/2001 | EP1082129A1 Method for the treatment of fertility disorders |
| 03/14/2001 | EP1082127A1 SUCCINAMIDE INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME |
| 03/14/2001 | EP1082124A1 Compositions comprising methotrexate and pentostatin for treating rheumatoid arthritis |
| 03/14/2001 | EP1082123A1 Use of a nucleic acid-binding chemotherapeutic agent, and a pharmaceutical composition |
| 03/14/2001 | EP1082122A1 Isoflavonoids for treatment and prevention of migraine headaches |
| 03/14/2001 | EP1082120A1 PYRROLO[2,3d]PYRIMIDINE COMPOSITIONS AND THEIR USE |
| 03/14/2001 | EP1082119A1 Microemulsion preconcentrates containing a piperidine substance p antagonist |
| 03/14/2001 | EP1082118A2 Methods for the normalization of sexual response and amelioration of long term genital tissue degradation |
| 03/14/2001 | EP1082117A1 A stabilized antihistamine syrup containing aminopolycarboxylic acid as stabilizer |
| 03/14/2001 | EP1082116A1 Use of 4-piperidinemethanol derivatives in treatment of neurodevelopmental disorders |
| 03/14/2001 | EP1082115A1 Heterocyclic cis cyclopropane derivatives as melatonergic agents |
| 03/14/2001 | EP1082114A1 Hydroxyomeprazole compositions and uses |
| 03/14/2001 | EP1082113A2 Compositions and methods for alleviating impaired mental function, memory loss and reducing recovery time in anaesthetized mammals |
| 03/14/2001 | EP1082112A1 Endogenous nitric oxide synthesis under conditions of low oxygen tension |
| 03/14/2001 | EP1082111A1 Assay for identification of compounds that promote melanin production and retinoid-like compounds identified by said assay |
| 03/14/2001 | EP1082110A1 Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 03/14/2001 | EP1082109A1 Oral formulation comprising biguanide and an organic acid |
| 03/14/2001 | EP1082107A1 Controlled release lipoic acid |
| 03/14/2001 | EP1082106A1 Sublingual buccal effervescent |
| 03/14/2001 | EP1082105A1 Controlled drug delivery system using the conjugation of drug to biodegradable polyester |
| 03/14/2001 | EP1082103A1 Spill resistant pharmaceutical compositions |
| 03/14/2001 | EP1082097A1 Use of sophorolipids comprising diacetyl lactones as agent for stimulating skin fibroblast metabolism |
| 03/14/2001 | EP1082095A1 N-oxide of heterocyclic ester, amide, thioester or ketone hair growth compositions and uses |
| 03/14/2001 | EP1082093A1 Anti-germ attachment - composition |